ClinConnect ClinConnect Logo
Search / Trial NCT00001479

Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression

Launched by NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH) · Dec 9, 2002

Trial Information

Current as of May 09, 2025

Completed

Keywords

Acth Adrenocorticotropic Hormone Antidepressant Treatment Chaos Theory Chronic Fatigue Syndrome Major Depression Normal Volunteer Primary Affective Disorder

ClinConnect Summary

Major depression represents a major public health problem worldwide and in the U.S. Fifteen percent of the U.S. population has depression at some point in life (40 million individuals), with a female to male ratio 5:2. Presently, 6-8% of all outpatients in primary care meet diagnostic criteria for major depression. Fifteen percent of untreated depressed patients commit suicide-most suicides have depression. In the U.S., in the year 2020 suicide will be the 10th cause of death. In addition to mortality due to suicide, major depression is associated with severe morbidity, that includes decrea...

Gender

ALL

Eligibility criteria

  • Patients with primary affective disorder (major depression), chronic fatigue syndrome, and control subjects.
  • Psychiatric diagnosis will be made by means of the Structured Clinical Diagnosis for DSM-III-R (SCID), performed by senior experienced clinicians.
  • Exclusion Criteria:
  • Subjects on chronic medications, which can not be washed out in one month.
  • Subjects with any serious medical illnesses which have been excluded.
  • Women who are pregnant, trying to become pregnant or sexually active and not using effective contraception.
  • Patients with HIV-1 infection.
  • Patients on chronic lithium therapy.
  • Subjects unable to discontinue alcohol, tobacco, or illegal drugs.

About National Institute Of Mental Health (Nimh)

The National Institute of Mental Health (NIMH) is a leading federal agency dedicated to advancing the understanding and treatment of mental health disorders through innovative research and clinical trials. As part of the National Institutes of Health (NIH), NIMH focuses on a broad spectrum of mental health issues, including mood disorders, anxiety disorders, schizophrenia, and developmental disorders. By fostering collaboration among researchers, clinicians, and the community, NIMH aims to translate scientific discoveries into effective interventions and improve mental health outcomes for individuals across the lifespan. Through its commitment to rigorous research methodologies and ethical standards, NIMH plays a pivotal role in shaping the future of mental health care and policy.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials